GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » FCF Yield %

ME Therapeutics Holding (XCNQ:METX) FCF Yield % : -0.59 (As of May. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, ME Therapeutics Holding's Trailing 12-Month Free Cash Flow is C$-0.61 Mil, and Market Cap is C$103.53 Mil. Therefore, ME Therapeutics Holding's FCF Yield % for today is -0.59%.

The historical rank and industry rank for ME Therapeutics Holding's FCF Yield % or its related term are showing as below:

XCNQ:METX' s FCF Yield % Range Over the Past 10 Years
Min: -1.34   Med: 0   Max: 0
Current: -0.59

XCNQ:METX's FCF Yield % is ranked better than
83.74% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs XCNQ:METX: -0.59

ME Therapeutics Holding's FCF Margin % for the quarter that ended in Feb. 2024 was 0.00%.

ME Therapeutics Holding FCF Yield % Historical Data

The historical data trend for ME Therapeutics Holding's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding FCF Yield % Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
FCF Yield %
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
FCF Yield % Get a 7-Day Free Trial - - - -9.00 -0.38

Competitive Comparison of ME Therapeutics Holding's FCF Yield %

For the Biotechnology subindustry, ME Therapeutics Holding's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's FCF Yield % distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's FCF Yield % falls into.


ME Therapeutics Holding FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

ME Therapeutics Holding's FCF Yield % for the fiscal year that ended in Aug. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.303 / 0
=N/A%

ME Therapeutics Holding's annualized FCF Yield % for the quarter that ended in Feb. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.099 * 4 / 103.9918
=-0.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

ME Therapeutics Holding FCF Yield % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines